BriaCell Therapeutics Corp Sustainability Reports
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops targeted, novel immunotherapies to transform cancer care. The company focuses primarily on clinical trials utilizing cell-based immunotherapies to treat advanced metastatic breast cancer and other solid tumors.
Sector: Manufacturing
Country: Canada
Exchange: Toronto Stock Exchange
LEI: 529900NQNTTXYE874283
2 reports from 2024 to 2025
